Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer

BMC Palliative Care

Volumn 3, Issue , 2004, Pages

  Barbetakis, Nikolaos ^a   Vassiliadis, Michalis ^a   Kaplanis, Konstantinos ^a   Valeri, Rosalia ^a   Tsilikas, Christodoulos ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; OVARY CANCER; PALLIATIVE THERAPY; PLEURA EFFUSION; PLEURA METASTASIS; PLEURODESIS; POSTOPERATIVE COMPLICATION; RASH; SURVIVAL; THORAX PAIN; TREATMENT OUTCOME; VOMITING;

EID: 5444230082     PISSN: 1472684X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-684X-3-4     Document Type: Article

References (29)

1. Hausheer FH, Yarbro JW: Diagnosis and treatment of malignant pleural effusion. Semin Oncol 1985, 12:54-75.
2. Lynch TJ: Management of malignant pleural effusions. Chest 1993, 103:385-389.
3. Saffran L, Ost D, Fein A, Schiff M: Outpatient pleurodesis of malignant pleural effusions using a small-bore pig tail catheter. Chest 2000, 118:417-421.
4. Dvoretsky PM, Richards KA, Bonfiglio TA: The pathology and behavior of ovarian cancer. Path Ann 1989, 24:1-24.
5. Ovary. In American Joint Committee on Cancer: AJCC Cancer Staging Manual 6th edition. New York, NY: Springer; 2002:275-284.
6. Statement of the American Thoracic Society: management of malignant pleural effusions. Am J Respir Crit Care Med 2000, 162:1987-2001.
7. Sahn SA: Pleural effusion in lung cancer. Clin Chest Med 1993, 14:189-2000.
8. Johnston WW: The malignant pleural effusion: a review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients. Cancer 1985, 56:905-909.
9. Antunes G, Neville E, Duffy J, Ali N: BTS guidelines for the management of malignant pleural effusions. Thorax 2003, 58:29-38.
10. Hausheer FH, Yarbro JW: Diagnosis and treatment of malignant pleural effusion. Cancer Metastasis Rev 1987, 6:23-40.
11. Patz E, McAdams P, Erasmus J, Goodman P, Culhane D, Gilkeson R, Herndon J: Sclerotherapy for malignant pleural effusions. A prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998, 113:1305-1311.
12. Seaton KG, Patz EF Jr, Goodman PC: Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. Am J Roentgen 1995, 164:589-591.
13. Cheng D, Chan YM, Ng T, Cheung A, Ngan H, Wong LC: Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynaecological cancer. Acta Obstet Gynecol Scand 1999:443-446.
14. Hartman DL, Gaither JM, Kesler KA: Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993, 105:743-748.
15. Gravelyn TR, Michelson MK, Gross BH: Tetracycline pleurodesis for malignant pleural effusions: a 10-year retrospective study. Cancer 1987, 59:1973-1977.
16. Goff BA, Mueller PR, Muntz HG: Small chest tube drainage followed by bleomycin sclerosis for malignant pleural effusions. Obstet Gynecol 1993, 81:993-996.
17. Moffet MJ, Ruckdeschel JC: Bleomycin and tetracycline in malignant pleural effusions: a review. Semin Oncol 1992, 19:59-63.
18. Ostrowski MJ: Intracavitary therapy with bleomycin for the treatment of malignant pleural effusions. J Surg Oncol 1989, 1:7-13.
19. Ruckdeschel JC, Moores D, Lee JY, Einhorn LH, Momdelbaum I, Koeller J, Weiss GR, Losada M, Koller JH: Intrapleural therapy for malignant pleural effusions: a randomised comparison of bleomycin and tetracycline. Chest 1991, 100(6):1528-1535.
20. Rehse DH, Aye RW, Florence MG: Respiratory failure following talc pleurodesis. Am J Surg 1999, 177:437-440.
21. Marom EM, Patz EF, Erasmus JJ, McAdams HP, Goodman PC, Herndon JE: Malignant pleural effusions: treatment with smallbore catheter thoracostomy and talc pleurodesis. Radiology 1999, 210:277-281.
22. Fingar BL: Sclerosing agents used to control malignant pleural effusions. Hosp Pharm 1992, 27:622-628.
23. Vargas FS, Teixeira LR, Antonangelo L, Silva IM, Strauz CM, Light RW: Acute and chronic pleural changes after intrapleural instillation of mitoxantrone in rabbits. Lung 1998, 176:227-236.
24. Seitzer D, Musch E, Kuhn W: Die locale behandlung maligner pleuraergusse bei gynakologischen tumoren. Zent Bl Gynakol 1990, 112:757-765.
25. Musch E, Loos U, Mackes KG: Intrapleural mitoxantrone in the treatment of malignant pleural effusions. In Advances in Regional Cancer Therapy 1st edition. Edited by: Kreidler H, Link KH, Aigner RB. Basel: Karger; 1988:184-189.
26. Maiche AG, Virkunnen P, Kontkanen T, Mokkynen K, Porkka K: Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. Am J Clin Oncol 1993, 16:50-53.
27. Van Belle AF, Velde GPM, Weuters EFM: Chemical pleurodesis with mitoxantrone in the management of malignant effusion. Eur J Cancer 1998, 34:206-207.
28. Morales M, Exposito MC: Intrapleural mitoxantrone for the palliative care treatment of malignant pleural effusions. Support Care Cancer 1995, 3:147-149.
29. Groth G, Gatzmeier U, Haussingen K, Heckmayr M, Magnussen H, Neuhauss R, Pavel JV: Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 1991, 2:213-215.